Samsung Medical Center: Neoplasm Metastasis trials

The registry lists 16 Neoplasm Metastasis studies with Samsung Medical Center as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 2 7Phase 3 2Phase 4 1No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Brain Metastasis Development Mechanism in BCBM PatientsRecruitingNCT06330870Not applicable
• Anesthesia and Non-small Cell Lung Cancer RecurrenceRecruitingNCT06330038Phase 4
• Central Nervous System(CNS) Efficacy of DacomitinibStatus unknownNCT04675008Phase 2
• Proton Beam Therapy for Unresectable Liver MetastasisCompletedNCT04456621Not applicable
• Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLCStatus unknownNCT03366376Phase 2
• Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMSStatus unknownNCT03257124Phase 2
• Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic CancerStatus unknownNCT02646228
• Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.CompletedNCT02593591
• Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.Status unknownNCT02593578
• Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib TherapyStatus unknownNCT02461849Phase 2
• Diffusion-Weighted Magnetic Resonance ImagingStatus unknownNCT02242786Phase 2
• Next pErsonalized Cancer tX With mulTi-omics and Preclinical ModelCompletedNCT02141152
• Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver MetastasisCompletedNCT02015169Phase 2
• Chemotherapy With or Without Radiosurgery for Asymptomatic Oligo Brain MetastasisStatus unknownNCT01301560Phase 3
• Asymptomatic Brain Metastasis in Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01130766Phase 3
• Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver MetastasisCompletedNCT00743678Phase 2